Nippon Kayaku Co., Ltd.TSE: 4272

Presentation Materials 2Q FY2026

Nov 11, 2026 at 12:06 AM EST · Issued by Nippon Kayaku Co., Ltd.

Summary by 6ix AI

Nippon Kayaku reported net sales of 134.0 bn yen for the first half (April 2026 to September 2026) of the fiscal year ending March 31, 2027, up 20.4 bn yen year on year. The company says net sales and every profit level were record highs for a first half, and it revised its full-year forecast upward.

Key details

First-half operating income was 14.9 bn yen, up 4.3 bn yen, and profit attributable to owners of parent was 16.1 bn yen, up 4.4 bn yen. Basic earnings per share were 109.91 yen, compared with 75.07 yen a year earlier.
First-half extraordinary income was 6.3 bn yen, including a 4.3 bn yen gain on sales of investment securities and a 3.0 bn yen gain on bargain purchase (an accounting gain from acquiring a business for less than the value of its net assets).
The full-year forecast is now net sales of 277.8 bn yen, up 6.9 bn yen from the August forecast, and operating income of 28.7 bn yen, up 1.4 bn yen. Forecast profit attributable to owners of parent is 24.1 bn yen, down 0.5 bn yen year on year.
The full-year exchange rate assumption was revised from 148.00 yen to 157.14 yen per US dollar. The company expects strong sales of Safety Systems, Functional Materials and Pharmaceuticals.
First-half net sales by segment: Mobility & Imaging 54.1 bn yen (up 7.8 bn yen), Fine Chemicals 39.3 bn yen (up 5.0 bn yen) and Life Science 40.6 bn yen (up 7.6 bn yen).

What’s still pending

The full-year figures for the fiscal year ending March 31, 2027 are forecasts. They include a projected return on equity of 8.7% and a projected return on invested capital of 6.3%.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/nippon-kayaku-presentation-materials-2q-fy2026

November 11, 2026

Financial Results

for the Second Quarter of Fiscal Year Ending March 31, 2027 (FY2026 2Q) Executive Summary FY2026 1H Business Results

Net Sales

134.0 bn yen

YoY︓＋20.4 bn

Operating Income

14.9 bn yen

YoY︓＋4.3 bn

1H Profit

16.1 bn yen

YoY︓＋4.4 bn

・Year-on-year: Increased net sales and profit

・Record-high interim results in net sales and at every profit level

FY2026 Business Forecasts ・In light of recent situations, the full-year forecast has been revised upward

Net Sales

277.8 bn yen

YoY︓＋35.9 bn

Operating Income

28.7 bn yen

YoY︓＋6.2 bn

Profit

241 bn yen

YoY︓-0.5 bn

S E C T I O N 1

FY2026 1H Business Results

(April 2026-September 2026)

Year-on-year: Increased revenue and profit

FY2026 1H Business Results

Non-operating income/loss: -0.1 bn;

extraordinary income/loss: +6.3 bn yen (of which, gains on investment security sales: +4.3 bn yen)

		FY2025 1H Actual	FY2026 1H Actual	Change (YoY)
		FY2025 1H Actual	FY2026 1H Actual	Amount	%
Net sales	（bn yen）	113.6	134.0	20.4	18.0
Operating income by industry segment	（bn yen）	15.5	19.3	3.8	24.8
Operating income	（bn yen）	10.6	14.9	4.3	40.3
Ordinary income	（bn yen）	10.8	14.8	4.0	36.6
Profit attributable to owners of parent	（bn yen）	11.7	16.1	4.4	37.5
Profit attributable to owners of parent/ share-basic (yen)		75.07	109.91	34.84	46.4
PBR		0.79 times	1.08 times	0.29	36.7
Exchange rate	(JPY／USD)	146.03	159.49	13.46	9.2

Forecasts as of Aug.
1H	%
133.8	102
18.5	105
13.7	109
13.8	107
13.1	123

Foreign exchange rate sensitivity: Net sales 4.4 bn yen, Operating income 0.2 bn yen

FY2026 1H Non-Operating/ Extraordinary Income and Loss

Extraordinary income increased, driven by a 4.3 bn gain on investment security sales and a 3.0 bn gain on bargain purchases

(bn yen）

	FY2025 1H Actual	FY2026 1H Actual	Change
Non-operating income (loss)	0.2	(0.1)	(0.3)
Exchange loss	(0.8)	(0.5)	0.3
Interest and dividend income	0.9	0.8	(0.1)
Gains from equity in affiliates	0.2	0.2	(0.0)
Others	0.0	(0.6)	(0.6)
Extraordinary income (loss)	5.7	6.3	0.6
Gains on sales of non-current assets	0.0	0.0	0.0
Losses on disposal of non-current assets	(0.5)	(0.4)	0.1
Gains on investment security sales	6.2	4.3	(1.9)
Gains on bargain purchase	ー	3.0	3.0
Loss arising from a step acquisition	ー	(0.7)	(0.7)
Others	ー	(0.0)	(0.0)

FY2026 1H Business Results by Segments Net sales

Mobility & Imaging
54.1 bn yen YoY︓＋7.8 bn yen
Safety Systems	43.2 bn yen	YoY ＋5.8
Polatechno	10.9 bn yen	＋2.0
Aero	0.0 bn yen	＋0.0

Fine Chemicals
39.3 bn yen YoY︓＋5.0 bn yen
Functional Materials	21.4 bn yen	YoY ＋2.9
Color Materials	13.3 bn yen	+0.3
Catalysts	4.6 bn yen	＋1.9

Life Science
40.6 bn yen YoY︓＋7.6 bn yen
Pharmaceuticals	35.1 bn yen	YoY ＋6.9
Agrochemicals	4.5 bn yen	＋0.6
Real Estate	1.0 bn yen	＋0.1

Operating income by industry segment

7.4 bn yen

YoY︓＋2.2 bn yen

6.9 bn yen

YoY︓＋2.0 bn yen

5.0 bn yen

YoY︓-0.4 bn yen

FY2026 1H Business Results by Sub-segments

(bn yen)

Real Estate

1.0 (+0.1)

Agrochemicals

(): Changes on YoY

Pharmaceuticals
35.1 (YoY: +6.9)
GE (Generic anti-cancer drugs)	12.3	YoY ＋1.3
BS (Biosimilars)	10.5	＋3.3
New drug, long-listed drugs, etc.	6.6	＋2.3
CDMO	3.0	＋0.2
Food Techno and others	2.7	-0.0

Pharmaceuticals

35.1 (+6.9)

4.5 (+0.6)

Net sales

Safety Systems

Safety Systems
43.2 (YoY:＋5.8)
NK (Japan)	7.1	YoY ＋0.7
KSE (Czech)	11.7	＋1.4
KSH (China)	12.2	＋2.0
KSM (Mexico)	5.4	＋0.4
KMY (Malaysia)	6.8	＋1.2

43.2 (+5.8)

Catalysts

4.6 (+1.9)

134.0 bn yen

(+20.4)

Polatechno

10.9 (+2.0)

Color Materials

13.3 (+0.3)

Functional Materials

21.4 (+2.9)

Aero

0.0 (+0.0)

S E C T I O N ２

FY2026 Business Forecasts

(April 2026-March 2027)

FY2026 Business Forecasts

Full year forecasts: Net sales have been revised upward by 6.9 bn, and operating income has also been revised upward by 1.4 bn accordingly

(bn yen)

	FY2025 Full year Actual	FY2026
	FY2025 Full year Actual	1H Actual	2H Forecast	Full-year Forecast	Change (YoY)	% (YoY)
Net sales	241.9	134.0	143.8	277.8	35.9	14.9
Operating income by industry segment	32.3	19.3	19.1	38.5	6.2	19.2
Operating income	22.5	14.9	13.8	28.7	6.2	27.8
Ordinary income	25.5	14.8	13.1	27.9	2.4	9.5
Profit attributable to owners of parent	24.6	16.1	8.0	24.1	-0.5	-2.2

Forecasts as of Aug.
Full-year	Change
270.9	6.9
37.1	1.3
27.3	1.4
27.0	0.9
22.9	1.2

・Full year forecasts: The exchange rate have been revised from 148.00 yen to 157.14 yen Sales of Safety Systems, Functional Materials, and Pharmaceuticals to be strong

The previous forecasts announced in August have been revised upward to reflect recent situations As a result of these revisions, ROE is projected to be 8.7% (YoY: -0.3, previously 8.4%)

and ROIC is projected to be 6.3% (YoY: +1.0, previously 6.0%)

FY2026 Business Forecasts by Segments

Full year net sales have been revised upward across all business units

(bn yen)

	FY2025 Full year Actual	FY2026
	FY2025 Full year Actual	1H Actual	2H Forecast	Full-year Forecast (A)	Change (YoY)	% (YoY)
Net Sales	241.9	134.0	143.8	277.8	35.9	14.9
Mobility & Imaging	94.7	54.1	54.8	108.9	14.2	15.0
Fine Chemicals	74.1	39.3	42.7	81.9	7.8	10.5
Life Science	73.0	40.6	46.3	87.0	14.0	19.1
Operating income by industry segment	32.3	19.3	19.1	38.5	6.2	19.2
Mobility & Imaging	10.7	7.4	6.7	14.2	3.5	33.1
Fine Chemicals	11.9	6.9	7.7	14.6	2.7	22.4
Life Science	9.7	5.0	4.7	9.7	-0.0	-0.1

Forecasts as of Aug.
Full-year (B)	Change (A-B)
270.9	6.9
107.4	1.5
78.7	3.2
84.8	2.2
37.1	1.3
13.4	0.8
13.0	1.6
10.7	-1.1

Presentation Materials 2Q FY2026

Summary by 6ix AI

Key details

What’s still pending

Earlier from Nippon Kayaku